Omnimmune Holdings IncOver The Counter Market:OMMH
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omnimmune Holdings Inc | 940.0 | 0.0x | --- |
Adhera Therapeutics Inc | 17.3K | 0.0x | --- |
Psycheceutical Bioscience Inc | 27.6K | 0.0x | --- |
eFFECTOR Therapeutics Inc | 940.0 | 0.0x | --- |
IR BioSciences Holdings Inc | 20.0 | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Company Information
Omnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic and prognostic technologies. The Company is the holding company of Omnimmune Corp. Omnimmune has acquired licensed rights to diagnostic and platform monoclonal antibody technologies. Omnimmune’s hCGß and related technologies, which are protected through an expanding intellectual property portfolio, have been developed at institutions including Columbia University of New York, New York (Columbia), The Allegheny-Singer Research Institute of the West Penn Allegheny Health System, Pittsburgh, Pennsylvania (Allegheny) and The Institute Gustave Roussy, Paris, France (IGR).
Contact Information
- Headquarters
- 4600 Post Oak Place Dr Ste 352HOUSTON, TX, United States 77027-9608
- Phone
- 713-622-8400
- Fax
- 302-655-5049
Executives
- Chief Executive Officer, Director
- Travis McPhee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $940.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 9.4M |
Omnimmune Holdings Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.20 |
Book Value | $-0.61 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
